Scientific work

Doç. Dr. Ayşe İrem Yasin

31 publications. The source of the information is stated next to each publication.

Back to profile

  1. Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors

    Medicina, 2025

    DOI 10.3390/medicina61071279 PMID 40731908 Open-access full textSource: OpenAlex

  2. Prevalence and co-incidence of geriatric syndromes according to the ECOG performance status in older cancer patients

    Frontiers in Medicine, 2024

    DOI 10.3389/fmed.2024.1331246 PMID 38439897 12 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram

    Supportive Care in Cancer, 2024

    DOI 10.1007/s00520-024-08702-0 PMID 38976108 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2366683 PMID 38904164 1 citation (Europe PMC) Source: OpenAlex

  5. Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2358458 PMID 38803194 Source: OpenAlex

  6. Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

    Current Oncology, 2024

    DOI 10.3390/curroncol31090384 PMID 39330012 Open-access full textSource: OpenAlex

  7. Differentiation of lung and breast cancer brain metastases: Comparison of texture analysis and deep convolutional neural networks

    Journal of Clinical Ultrasound, 2023

    DOI 10.1002/jcu.23558 PMID 37688435 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. The risk of malnutrition and its clinical implications in older patients with cancer

    Aging Clinical and Experimental Research, 2023

    DOI 10.1007/s40520-023-02538-0 PMID 37644257 20 citations (Europe PMC) Source: OpenAlex

  9. Local interventions for colorectal cancer metastases to liver and lung

    Irish Journal of Medical Science (1971 -), 2023

    DOI 10.1007/s11845-023-03340-7 PMID 36929352 3 citations (Europe PMC) Source: OpenAlex

  10. The Correlation Between Skeletal Muscle Index and Anxiety in Patients with Lung Cancer on the First Day of Chemotherapy

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1200 PMID 37367530 2 citations (Europe PMC) Source: OpenAlex

  11. The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study

    International Journal of Gastrointestinal Intervention, 2023

    DOI 10.18528/ijgii220012 Source: OpenAlex

  12. The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma

    Bosnian Journal of Basic Medical Sciences, 2022

    DOI 10.17305/bjbms.2022.7147 PMID 35575465 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  13. The efficacy of BNT162b2 (Pfizer–BioNTech) and CoronaVac vaccines in patients with cancer

    Journal of Medical Virology, 2022

    DOI 10.1002/jmv.27835 PMID 35513241 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  14. Impact of Malnutrition on Prognosis in Patients with HER2-negative Metastatic Gastric Cancer

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2022

    DOI 10.4274/bmj.galenos.2022.2022.4-7 Source: OpenAlex

  15. Is There a Relation Between Pretreatment CONUT Score and Neoadjuvant Chemotherapy Response in Breast Cancer Patients?

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2022

    DOI 10.4274/bmj.galenos.2022.2022.2-8 Source: OpenAlex

  16. Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study

    Future Oncology, 2022

    DOI 10.2217/fon-2021-1248 PMID 35081732 27 citations (Europe PMC) Open-access full textSource: OpenAlex

  17. Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy

    Annals of Diagnostic Pathology, 2022

    DOI 10.1016/j.anndiagpath.2022.151930 PMID 35245821 10 citations (Europe PMC) Source: OpenAlex

  18. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

    Expert Review of Anticancer Therapy, 2022

    DOI 10.1080/14737140.2022.2076670 PMID 35543015 3 citations (Europe PMC) Source: OpenAlex

  19. The Effect of Intratumoral Budding and Other Histological Features in Predicting Treatment Response in Breast Cancer Patients Receiving Neoadjuvant Therapy

    Istanbul Medical Journal, 2022

    DOI 10.4274/imj.galenos.2022.69741 Source: OpenAlex

  20. Uncommon Testicular Germ Cell Tumor Thrombus in Azygos Vein Detected by FDG PET/CT

    Clinical Nuclear Medicine, 2021

    DOI 10.1097/rlu.0000000000003588 PMID 33782290 1 citation (Europe PMC) Source: OpenAlex

  21. A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211027931 PMID 34162247 14 citations (Europe PMC) Source: OpenAlex

  22. Anxiety Levels of Breast Cancer Patients in Turkey During the COVID-19 Pandemic

    Future Oncology, 2021

    DOI 10.2217/fon-2020-1265 PMID 34291649 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  23. A comparison of anticholinergic burden in older patients with and without cancer

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0469 PMID 34704458 6 citations (Europe PMC) Source: OpenAlex

  24. Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0398 PMID 34323116 2 citations (Europe PMC) Source: OpenAlex

  25. Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.01.39 PMID 33546531 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  26. Metastatic Breast Carcinoma Mimicking Urothelial Carcinoma

    International Journal of Surgical Pathology, 2021

    DOI 10.1177/10668969211067923 PMID 34955060 Source: OpenAlex

  27. Is the Duration of Temozolomide Predictive for Sequential Bevacizumab Treatment Responses in the Glioblastoma Multiforme Cancer Setting?

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.08.932 PMID 34320710 Source: OpenAlex

  28. Endokrin Sistem Tümörleri

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.353 Source: OpenAlex

  29. Preventing Geriatric Oncology Patients from the Spread of COVID-19

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2020-76410 Source: OpenAlex

  30. Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients

    Oncology Research and Treatment, 2018

    DOI 10.1159/000490120 PMID 30121640 5 citations (Europe PMC) Source: OpenAlex

  31. 22. Oruç Z, Kaplan MA, Karaağaç M, Özyurt N, Tatlı AM, Kaya AO, Menekşe S, Kut E, Koca S, Sever ÖN, Yasin İ, Ebinç S, Zeynelgil E, Sakin A, Turhal NS, Isikdogan A. Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases. Future Oncol. 2021 May;17(13):1611-1624. doi: 10.2217/fon-2020-1032. Epub 2021 Feb 26. PMID: 33631986.

    Source: medipol.com.tr profile page